[1]黄浩  李光仪.卵巢癌的治疗进展[J].中国微创外科杂志,2002,02(6):430-432.
点击复制

卵巢癌的治疗进展()
分享到:

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
02
期数:
2002年6期
页码:
430-432
栏目:
文献综述
出版日期:
2002-12-31

文章信息/Info

作者:
黄浩  李光仪
广东省佛山市第一人民医院妇产科,佛山,528000
关键词:
卵巢癌 腹膜后淋巴结切除术 细胞减灭术 二次减瘤术 二次探查术 腹腔镜
分类号:
R737.31
文献标志码:
A
摘要:
全面准确分期的剖腹手术,是完成治疗、准确分期及决定辅助治疗的基础.对早期卵巢癌行腹膜后淋巴结切除的合理性及其意义尚有争议.晚期卵巢癌能达到理想的细胞减灭术标准(残余肿瘤<2cm)者生存率较高,反之则不能改善生存率.卵巢癌以手术治疗为主,辅助化疗具有重要意义.二次手术有一定的临床意义.二次探查术并不能延长患者的生存期及减少复发率,因此不主张常规施行.6个疗程未能取得客观疗效者再增加疗程也不能产生疗效,故不主张长时间维持化疗.超大剂量化疗并未能明显改善预后.腹腔镜技术在卵巢恶性肿瘤的诊断和随访中有其独特的优越性,而手术治疗的应用尚有待进一步深入探讨.

参考文献/References:

[1]沈铿,郎景和,连利娟,等.Ⅰ期卵巢上皮性癌全面分期探查术的临床意义.中华妇产科杂志,1996,31:390-393.
[2]王文福,霍汝娟. Ⅰ期卵巢上皮性癌合理治疗模式的探讨.中华妇产科杂志,1996,31:387-389.
[3]Curtin JP,Malik R,Venkatraman ES,et al. Stage IV ovarian cancer: impact of surgical debulking.Gynecol Oncol,1997,64(1):9-12.
[4]Vaccarello L,Rubin SD,Viamis V,et al.Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.Gynecol Oncol,1995,57(1):61-65.
[5]Janicke F,Holscher M,Kuhn W,et al.Radical surgical procedure improves survival time in patients with ovarian cancer.Cancer ,1992,70:2129-2136.
[6]Friedman RL,Eisenkop SM,Wang HJ.Second look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.Gyneco Oncol,1997,67(1):88-94.
[7]高永良.卵巢癌治疗的进展.国外医学妇产科学分册,1999,26(2):88-93.
[8]连利娟主编.林巧稚妇科肿瘤学.第3版.北京:人民卫生出版社,2000.495-501.
[9]McGuire WP,Hoskins WJ,Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Eng1 J Med,1996,334(1):1-6.
[10]Alberts DS,Liu PY,Hannigan EV, et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.N Eng1 J Med,1996,335(26):1950-1955.
[11]McGuire WP,Hoskins WJ,Brady MF, et al. Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.J Clin Oncol,1995,13:1589-1599.
[12]Conte PF,Bruzzone M,Carnino F, et al. High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.J Clin Oncol,1996,14:351-356.
[13]Childers JM,Lang J,Surwit EA,et al.Laparoscopic surgical staging of ovarian cancer.Gynecol Oncol,1995,59:25-33.
[14]Pomel C,Provencher D,Dauplat J,et al.Laparoscopic staging of early ovarian cancer.Gynecol Oncol,1995,58:301-306.
[15]Vinatier D,Dufour P,Cosson M,et al.Laparoscopy in gynaecological cancer. Surg Oncol,1996,5:211-220.
[16]Chu KK, Chen FP, Chang SD. Laparoscopic surgical procedures for early ovarian cancer. Acta Obstet Gynecol Scand,1995,74:361-362.
[17]Vergote I,De Wever I,Tjalma W,et al.Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.Gynecol Oncol,1998,71:431-436.
[18]Kruitwagen RF,Swinkels BM,Keyser KG,et al.Incidence and effect on survival of abdominal wall metastases at trocar or puncture sites following laparoscopy or paracentesis in women with ovarian cancer. Gynecol Oncol,1996,60:233-237.

更新日期/Last Update: 2014-07-31